Clal Insurance’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $543M | Sell |
|
|||||
|
2025
Q1 | $578M | Sell |
|
|||||
|
2024
Q4 | $860M | Buy |
|
|||||
|
2024
Q3 | $621M | Buy |
|
|||||
|
2024
Q2 | $526M | Buy |
|
|||||
|
2024
Q1 | $406M | Sell |
|
|||||
|
2023
Q4 | $343M | Buy |
|
|||||
|
2023
Q3 | $312M | Sell |
|
|||||
|
2023
Q2 | $238M | Buy |
|
|||||
|
2023
Q1 | $161M | Buy |
|
|||||
|
2022
Q4 | $169M | Sell |
|
|||||
|
2022
Q3 | $155M | Buy |
|
|||||
|
2022
Q2 | $138M | Buy |
|
|||||
|
2022
Q1 | $168M | Hold |
|
|||||
|
2021
Q4 | $138M | Sell |
|
|||||
|
2021
Q3 | $172M | Buy |
|
|||||
|
2021
Q2 | $157M | Buy |
|
|||||
|
2021
Q1 | $166M | Sell |
|
|||||
|
2020
Q4 | $131M | Buy |
|
|||||
|
2020
Q3 | $125M | Sell |
|
|||||
|
2020
Q2 | $202M | Buy |
|
|||||
|
2020
Q1 | $120M | Buy |
|
|||||
|
2019
Q4 | $4.93M | Sell |
|
|||||
|
2019
Q3 | $17.9M | Hold |
|
|||||
|
2019
Q2 | $24M | Sell |
|
|||||
|
2019
Q1 | $48.4M | Sell |
|
|||||
|
2018
Q4 | $58.3M | Buy |
|
|||||
|
2018
Q3 | $39.1M | Buy |
|
|||||
|
2018
Q2 | $16.4M | Buy |
|
|||||
|
2018
Q1 | $10.7M | Sell |
|
|||||
|
2017
Q4 | $28.9M | Sell |
|
|||||
|
2017
Q3 | $54.2M | Buy |
|
|||||
|
2017
Q2 | $99.3M | Buy |
|
|||||
|
2017
Q1 | $54.8M | Sell |
|
|||||
|
2016
Q4 | $68M | Sell |
|
|||||
|
2016
Q3 | $146M | Sell |
|
|||||
|
2016
Q2 | $161M | Sell |
|
|||||
|
2016
Q1 | $240M | Buy |
|
|||||
|
2015
Q4 | $275M | Sell |
|
|||||
|
2015
Q3 | $246M | Buy |
|
|||||
|
2015
Q2 | $253M | Buy |
|
|||||
|
2015
Q1 | $255M | Sell |
|
|||||
|
2014
Q4 | $256M | Buy |
|